Abstract
Intravesical instillation of BCG, first described in 1976, has now attained widespread usage in the treatment of superficial transitional cell carcinoma of bladder. Its impact has been greatest in high grade disease, notably carcinoma in situ where until recently a prophylactic cystoprostatectomy was routinely carried out because of the high risk of progression to incurable disease. The 381 pages of this book attest to the enthusiasm for intravesical BCG but also to the fact that this is the book of a meeting — held in fact in September 1988. British urologists have only recently taken up this type of treatment and will find this volume most useful, bringing together most of those who have published on the subject.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
